L. Mao, W. K. Hong, and V. A. Papadimitrakopoulou, Focus on head and neck cancer, Cancer Cell, vol.5, pp.311-316, 2004.

C. A. Glazer, S. S. Chang, P. K. Ha, and J. A. Califano, Applying the molecular biology and epigenetics of head and neck cancer in everyday clinical practice, Oral oncology, vol.45, pp.440-446, 2009.

Z. Wang, J. C. Valera, X. Zhao, Q. Chen, and J. S. Gutkind, MTOR co-targeting strategies for head and neck cancer therapy, Cancer Metastasis Rev, vol.36, pp.491-502, 2017.

D. A. Fruman and C. Rommel, PI3K and cancer: lessons, challenges and opportunities, Nat Rev Drug Discov, vol.13, pp.140-156, 2014.
DOI : 10.1038/nrd4204
URL : http://europepmc.org/articles/pmc3994981?pdf=render

Z. Wang, D. Martin, and A. A. Molinolo, MTOR co-targeting in cetuximab resistance in head and neck cancers harboring PIK3CA and RAS mutations, J Natl Cancer Inst, vol.106, p.215, 2014.

R. Iglesias-bartolome, D. Martin, and J. S. Gutkind, Exploiting the head and neck cancer oncogenome: widespread PI3K-mTOR pathway alterations and novel molecular targets, Cancer Discov, vol.3, pp.722-725, 2013.
DOI : 10.1158/2159-8290.cd-13-0239
URL : http://cancerdiscovery.aacrjournals.org/content/3/7/722.full.pdf

D. Palma, M. Biziato, D. Petrova, and T. V. , Microenvironmental regulation of tumour angiogenesis, Nat Rev Cancer, vol.17, pp.457-474, 2017.

K. Tjioe, T. Oliveira, D. Gavard, and J. , Luteolin impacts on the DNA damage pathway in oral squamous cell carcinoma, Nutr Cancer, vol.68, pp.838-647, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01333887

F. J. Oliver, G. De-la-rubia, V. Rolli, M. C. Ruiz-ruiz, G. De-murcia et al., Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant, J Biol Chem, vol.273, pp.33533-33539, 1998.

J. D. Van-buul, D. Geerts, and S. Huveners, Rho GAPs and GEFs: controling switches in endothelial cell adhesion, Cell Adh Migr, vol.8, pp.108-124, 2014.

L. Lamalice, L. Boeuf, F. Huot, and J. , Endothelial cell migration during angiogenesis, Circ Res, vol.100, pp.782-794, 2007.
DOI : 10.1161/01.res.0000259593.07661.1e
URL : http://circres.ahajournals.org/content/circresaha/100/6/782.full.pdf

X. L. Chen, J. O. Nam, and C. Jean, VEGF-induced vascular permeability is mediated by FAK, Dev Cell, vol.22, pp.146-157, 2012.
DOI : 10.1016/j.devcel.2011.11.002
URL : https://doi.org/10.1016/j.devcel.2011.11.002

A. M. Martelli, F. Buontempo, and J. A. Mccubrey, Drug discovery targeting the mTOR pathway, Clin Sci (Lond), vol.132, pp.543-568, 2018.
DOI : 10.1042/cs20171158

M. R. Tavares, I. C. Pavan, C. L. Amaral, L. Meneguello, A. D. Luchessi et al., The S6K protein family in health and disease, Life Sci, vol.131, pp.1-10, 2015.
DOI : 10.1016/j.lfs.2015.03.001

C. H. Chen and . Sarbassov, The mTOR (mammalian target of rapamycin) kinase maintains integrity of mTOR complex 2, J Biol Chem, vol.286, pp.40386-40394, 2011.

R. A. Saxton and D. M. Sabatini, MTOR signaling in growth, metabolism, and disease, Cell, vol.169, pp.361-371, 2017.
DOI : 10.1016/j.cell.2017.03.035
URL : http://europepmc.org/articles/pmc5394987?pdf=render

D. K. Lau, R. Y. Tay, and Y. H. Yeung, Phase II study of everolimus monotherapy as first-line treatment in advanced biliary tract cancer: RADichol, Br J Cancer, vol.118, pp.966-971, 2018.

J. R. Basile, J. Gavard, and J. S. Gutkind, Plexin-B1 utilizes RhoA and Rho kinase to promote the integrin-dependent activation of Akt and ERK and endothelial cell motility, J Biol Chem, vol.282, pp.34888-34895, 2007.

W. Tan, T. R. Palmby, J. Gavard, P. Amornphimoltham, Y. Zheng et al., An essential role for Rac1 in endothelial cell function and vascular development, FASEB J, vol.22, pp.1829-1838, 2008.

G. André-grégoire, N. Bidère, and J. Gavard, Temozolomide affects extracellular vesicles released by glioblastoma cells, Biochimie, vol.18, pp.30041-30045, 2018.

Q. Feng, C. Zhang, and D. Lum, A class of extracellular vesicles from breast cancer cells activates VEGF receptors and tumour angiogenesis, Nat Comm, vol.8, p.14450, 2017.

M. Matsuki, Y. Adachi, and Y. Ozawa, Targeting of tumor growth and angiogenesis underlies the enhanced antitumor activity of lenvatinib in combination with everolimus, Cancer Sci, vol.108, pp.763-771, 2017.

A. Duarte, G. André-grégoire, and K. Trillet, Inhibition of mTOR in head and neck cancer cells alters endothelial cell morphology in a paracrine fashion
URL : https://hal.archives-ouvertes.fr/inserm-01908781

, Molecular Carcinogenesis, pp.1-8, 2018.

,